Na

. Arrhythmogenic cardiomyopathy (AC) is a heart muscle disease characterized by a progressive replacement of the ventricular myocardium with adipose and fibrous tissue. This disease is often associated with mutations in genes encoding desmosomal proteins in the majority of patients. Based on results...

Full description

Saved in:
Bibliographic Details
Published inFuture cardiology Vol. 9; no. 4; pp. 467 - 470
Main Authors Gillet, Ludovic, Shy, Diana, Abriel, Hugues
Format Journal Article
LanguageEnglish
Published Future Medicine Ltd 01.07.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract . Arrhythmogenic cardiomyopathy (AC) is a heart muscle disease characterized by a progressive replacement of the ventricular myocardium with adipose and fibrous tissue. This disease is often associated with mutations in genes encoding desmosomal proteins in the majority of patients. Based on results obtained from recent experimental models, a disturbed distribution of gap junction proteins and cardiac sodium channels may also be observed in AC phenotypes, secondary to desmosomal dysfunction. The study from Noorman et al. examined heart sections from patients diagnosed with AC and performed immunohistochemical analyses of N-cadherin, PKP2, PKG, Cx43 and the cardiac sodium channel Na 1.5. Altered expression/distribution of Cx43, PKG and Na 1.5 was found in most cases of patients with AC. The altered expression and/or distribution of Na 1.5 channels in AC hearts may play a mechanistic role in the arrhythmias leading to sudden cardiac death in AC patients. Thus, Na 1.5 should be considered as a supplemental element in the evaluation of risk stratification and management strategies. However, additional experiments are required to clearly understand the mechanisms leading to AC phenotypes.
AbstractList . Arrhythmogenic cardiomyopathy (AC) is a heart muscle disease characterized by a progressive replacement of the ventricular myocardium with adipose and fibrous tissue. This disease is often associated with mutations in genes encoding desmosomal proteins in the majority of patients. Based on results obtained from recent experimental models, a disturbed distribution of gap junction proteins and cardiac sodium channels may also be observed in AC phenotypes, secondary to desmosomal dysfunction. The study from Noorman et al. examined heart sections from patients diagnosed with AC and performed immunohistochemical analyses of N-cadherin, PKP2, PKG, Cx43 and the cardiac sodium channel Na 1.5. Altered expression/distribution of Cx43, PKG and Na 1.5 was found in most cases of patients with AC. The altered expression and/or distribution of Na 1.5 channels in AC hearts may play a mechanistic role in the arrhythmias leading to sudden cardiac death in AC patients. Thus, Na 1.5 should be considered as a supplemental element in the evaluation of risk stratification and management strategies. However, additional experiments are required to clearly understand the mechanisms leading to AC phenotypes.
Author Shy, Diana
Gillet, Ludovic
Abriel, Hugues
AuthorAffiliation 1Department of Clinical Research, Ion Channel Research Group, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland
1Department of Clinical Research, Ion Channel Research Group, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland. hugues.abriel@dkf.unibe.ch
AuthorAffiliation_xml – name: 1Department of Clinical Research, Ion Channel Research Group, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland. hugues.abriel@dkf.unibe.ch
– name: 1Department of Clinical Research, Ion Channel Research Group, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland
Author_xml – sequence: 1
  givenname: Ludovic
  surname: Gillet
  fullname: Gillet, Ludovic
– sequence: 2
  givenname: Diana
  surname: Shy
  fullname: Shy, Diana
– sequence: 3
  givenname: Hugues
  surname: Abriel
  fullname: Abriel, Hugues
BookMark eNqdjcEKAiEURR_DBM1Uiz5E86mNuo6iVav2IvYEowyy-f8m6gtanXsWl9NDWx6FANYouJRoNikGjoor20CHRmtmpbPttLVxbBiMnUNf61UIZRy6DppTWMIshVul1Y8L2B72592RpfE1PqnGTCWS_9qdLjnmQh6F_wT9FPSovLLq398bkq82rg
ContentType Journal Article
DOI 10.2217/fca.13.38
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1744-8298
EndPage 470
ExternalDocumentID 10_2217_fca_13_38
GroupedDBID -
0R
29H
3V.
4.4
53G
5GY
70G
7X7
88E
8AO
8FI
8FJ
AAWTL
ABUWG
ACGFS
ADBBV
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
BBAFP
BENPR
BPHCQ
BVXVI
CS3
EBS
EHMNL
F5P
FYUFA
H13
HZ
IAO
IEA
IHR
INH
INR
ITC
M1P
MV1
NTCAX
O9-
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
RFM
ID FETCH-futurescience_futuremedicine_10_2217_fca_13_383
ISSN 1479-6678
IngestDate Tue Jan 05 21:38:12 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-futurescience_futuremedicine_10_2217_fca_13_383
ParticipantIDs futurescience_futuremedicine_10_2217_fca_13_38
ProviderPackageCode NTCAX
RFM
70G
PublicationCentury 2000
PublicationDate 2013-July-01
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-July-01
  day: 01
PublicationDecade 2010
PublicationTitle Future cardiology
PublicationYear 2013
Publisher Future Medicine Ltd
Publisher_xml – name: Future Medicine Ltd
SSID ssj0037919
Score 3.8922987
Snippet . Arrhythmogenic cardiomyopathy (AC) is a heart muscle disease characterized by a progressive replacement of the ventricular myocardium with adipose and...
SourceID futurescience
SourceType Publisher
StartPage 467
SubjectTerms 1.5
arrhythmogenic cardiomyopathy
connexin 43
immunohistochemistry
intercalated disk
Na
Title Na
URI http://dx.doi.org/10.2217/fca.13.38
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1dS8Mw8JgbiCLiJ36zB19btyZpm8epm0NYEZmwt5K0qeylg7H64K_30rRdqz44X0Ib8nHkrvfV3B3AbcR6kjPZsxRnwqJRgt8ck4mFxOQh4FHi5z7dSeCO3-jzjM3WNTPz6JKVtKPPX-NK_oNV7EO86ijZDTBbLYod-Iz4xRYxjO2fcByIum45ytOD6FzT8bzhLH_S8X7GAs_ixcc8qtwq5ogfkUQq7jyQaDybDNfZe6YabgFdosGruwWKLSfFD_raHSHN5ajHLdc1tXNsZfo8Si3fMSWhS9bIaxRAa2yOmhIahcSkpvTHd2bsOHkGpyQSdp_YxF9LnOoeIFogelSIY8I-CYm_BR3H4wyt6M79MHh5LYUq8Xheo6WC3CSJ0pPvqg12Yc8kYmkoD7miMD2A_ULD7w4Mug6hpdIj2C6P6BhagTgBNhpOH8ZWY6HQvJW3HcIfYJNTaKeLVJ1Bl1M_lo6vHJWg4O9JkaBBR2ImXKETDZFzsDdb-2LTCZewsyaIK2ivlpm6Rs1pJW-KU_0Csx8eYw
link.rule.ids 315,786,790,27957,27958
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Na&rft.jtitle=Future+cardiology&rft.au=Gillet%2C+Ludovic&rft.au=Shy%2C+Diana&rft.au=Abriel%2C+Hugues&rft.date=2013-07-01&rft.pub=Future+Medicine+Ltd&rft.issn=1479-6678&rft.eissn=1744-8298&rft.volume=9&rft.issue=4&rft.spage=467&rft.epage=470&rft_id=info:doi/10.2217%2Ffca.13.38&rft.externalDocID=10_2217_fca_13_38
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-6678&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-6678&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-6678&client=summon